Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Deferred Taxes (2016 - 2017)

Historic Deferred Taxes for Wave Life Sciences (WVE) over the last 3 years, with Q4 2017 value amounting to $4000.0.

  • Wave Life Sciences' Deferred Taxes rose 10045.66% to $4000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $908000.0, marking a year-over-year increase of 23008.6%. This contributed to the annual value of $908000.0 for FY2017, which is 23008.6% up from last year.
  • According to the latest figures from Q4 2017, Wave Life Sciences' Deferred Taxes is $4000.0, which was up 10045.66% from $772000.0 recorded in Q3 2017.
  • In the past 5 years, Wave Life Sciences' Deferred Taxes ranged from a high of $772000.0 in Q3 2017 and a low of -$876000.0 during Q4 2016
  • Its 3-year average for Deferred Taxes is $20500.0, with a median of $48500.0 in 2015.
  • Over the last 5 years, Wave Life Sciences' Deferred Taxes had its largest YoY gain of 57708.33% in 2017, and its largest YoY loss of 376000.0% in 2017.
  • Quarter analysis of 3 years shows Wave Life Sciences' Deferred Taxes stood at -$146000.0 in 2015, then plummeted by 500.0% to -$876000.0 in 2016, then skyrocketed by 100.46% to $4000.0 in 2017.
  • Its Deferred Taxes was $4000.0 in Q4 2017, compared to $772000.0 in Q3 2017 and $325000.0 in Q2 2017.